Third Circuit Rejects Challenges to Medicare Drug Price Negotiation Program
- September 12, 2025
The Third Circuit rejected challenges to the Medicare drug price negotiation program brought by drug makers Novartis Pharmaceutical Corp., Johnson & Johnson’s Janssen Pharmaceuticals Inc., and Bristol Myers Squibb Co. (BMS), marking more wins for the government in a slew of similar lawsuits.
ARTICLE TAGS
You must be logged in to access this content.